Evaluation of hypertension in systemic sclerosis and systemic lupus erythematosus overlap

Erin Chew1, April Barnado1, Talat Alp Ikizler2,3

  • 1Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Insights

Diagnosing and managing hypertension in patients with overlapping systemic sclerosis and systemic lupus erythematosus requires careful consideration of treatment differences. Advanced imaging techniques can help assess long-term vasculopathy progression in these complex cases.

Area of Science:

  • Rheumatology
  • Nephrology
  • Cardiology

Background:

  • Hypertension in patients with overlapping systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) presents unique clinical challenges.
  • Treatment strategies for non-renal crisis hypertension differ significantly between SSc and SLE.
  • Early and accurate diagnosis is crucial for effective management.

Purpose of the Study:

  • To discuss the diagnostic approach for patients with SSc and SLE overlap who present with hypertension.
  • To highlight the importance of differentiating management strategies based on underlying autoimmune serologies.
  • To explore the role of advanced imaging in assessing long-term vasculopathy.

Main Methods:

  • Review of current literature on hypertension management in SSc and SLE overlap.
  • Discussion of diagnostic criteria and urgent laboratory studies.
  • Evaluation of imaging modalities for assessing vasculopathy.

Main Results:

  • Urgent laboratory studies and, in symptomatic cases, imaging are indicated for SSc-SLE overlap patients with hypertension.
  • Non-contrast imaging advances offer potential biomarkers for progressive vasculopathy.
  • Distinct treatment choices exist for non-renal crisis hypertension in SSc versus SLE.

Conclusions:

  • A tailored diagnostic and management approach is essential for hypertensive patients with SSc-SLE overlap.
  • Long-term monitoring using advanced imaging can improve assessment of vasculopathy.
  • Understanding the nuances between SSc and SLE is critical for optimal patient outcomes.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
14
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
43
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
29
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
23